“…Chemodynamic therapy (CDT), utilizing Fenton agents to converse H 2 O 2 into lethal hydroxyl radicals ( • OH) in situ, has attracted attention as an emerging strategy for cancer therapy . It demonstrates high therapeutic specificity due to the specific overexpression of H 2 O 2 in the tumor microenvironment (TME), leading to localized catalysis with minimal toxicity to normal tissues. , Numerous agents, such as metal ion-containing nanoparticles, organic frameworks, and single-atom nanozymes have been shown to exhibit Fenton or Fenton-like activity to enhance CDT effect. , Iron oxide nanoparticles (Fe 3 O 4 NPs, IONPs) exhibit minor cytotoxicity in normal tissues, while in acidic pH conditions in the tumor region, they can ionize to produce Fe 2+ , catalyzing H 2 O 2 to generate • OH. , Despite the high levels in cancer cells (0.1–1 mM), the intratumoral H 2 O 2 remains insufficient for IONPs to produce adequate • OH for desired CDT efficacy. , Additionally, overproduced intracellular GSH mediates potent • OH scavenging in cancer cells, thereby weakening the effect. , Consequently, the simultaneous amplification of the intracellular H 2 O 2 supply for Fenton reactions and GSH elimination in a single formulation is highly desirable.…”